Summary & Overview
HCPCS J7306: Levonorgestrel Implant System, Includes Implants and Supplies
HCPCS Level II code J7306 identifies the levonorgestrel contraceptive implant system, covering the implants and necessary supplies for subdermal, long-acting reversible contraception. Nationally, this code matters because it standardizes billing for a widely used contraceptive device that affects reproductive health access, continuity of care, and payer coverage policies across outpatient settings.
Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise national perspective on coverage relevance, common clinical settings for use, and the administrative footprint of the code.
This publication summarizes what J7306 represents clinically and administratively, outlines typical sites of service, and identifies common payer stakeholders. It flags the types of benchmarks and policy signals readers should expect in a full analysis — including coverage consistency, prior authorization patterns, and supply bundling considerations — while providing clinical context for device use. Data not available in the input will be noted where applicable.
Billing Code Overview
HCPCS Level II code J7306 describes a levonorgestrel (contraceptive) implant system, including implants and supplies. This code represents the device and associated supplies used for long-acting reversible contraception delivered via subdermal implant.
Service Type: Contraceptive device implantation (long-acting reversible contraception)
Typical Site of Service: Outpatient clinic, physician office, or ambulatory surgical center
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 26-year-old nulliparous woman presents to an outpatient family planning clinic requesting long-acting reversible contraception. She desires an implantable levonorgestrel system for continuous contraception for up to three years. After a focused history and brief physical exam confirming no contraindications (no current pregnancy, no active pelvic infection, no unexplained vaginal bleeding), the patient completes informed consent and the implant procedure is scheduled.
On the day of service the patient is positioned supine in a minor procedure room. The non-dominant upper arm is prepped and marked. Local anesthesia is administered. The clinician inserts the levonorgestrel implant(s) subdermally using the manufacturer’s applicator; supplies and implant are provided as part of the device procedure. Hemostasis is achieved, the insertion site is dressed, and the patient receives aftercare instructions including signs of infection, when to return for removal, and documentation of device lot and serial number in the chart. Follow-up is arranged in 1–4 weeks to confirm placement and address any complications.
Typical site of service: outpatient clinic, family planning or gynecology office, ambulatory surgery center for complex cases. Service type: contraceptive device insertion (implant system) including implants and supplies.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier—standard billing |